|
Ritonavir-d6
|
利托那韋-d6
|
155213-67-5
|
|
Sofosbuvir
|
索非布韋
|
1190307-88-0
|
|
sofosbuvir impurity 26;(R)-isopropyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
|
索非布韋雜質(zhì)26
|
|
|
Sofosbuvir IMpurity 2
|
索非布韋雜質(zhì)2
|
|
|
sofosbuvir impurity 16
|
索非布韋雜質(zhì)10
|
2041584-99-8
|
|
Sofosbuvir IMpurity 33
|
索非布韋雜質(zhì)33
|
|
|
Ritonavir EP Impurity O
|
利托那韋EP雜質(zhì)O
|
1414933-81-5
|
|
Tadalafil Impurity 11
|
他達(dá)拉非雜質(zhì)11
|
1492563-70-8
|
|
Tadalafil Impurity 26
|
他達(dá)拉非雜質(zhì)1
|
171752-68-4
|
|
Ritonavir Impurity 4
|
利托那韋雜質(zhì)4
|
1010809-54-7
|
|
sofosbuvir impurity 25;(S)-isopropyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
|
索非布韋雜質(zhì)25
|
|
|
Sofosbuvir IMpurity 4
|
索非布韋雜質(zhì)4
|
|
|
Riluzole Impurity 2
|
利魯唑雜質(zhì)
|
1456696-94-8
|
|
Tacrolimus 31-DMT
|
他克莫司 31-DMT雜質(zhì)
|
127984-76-3
|
|
sitafloxacin hydrate Impurity 6
|
西他沙星雜質(zhì)6
|
|
|
sitafloxacin hydrate Impurity 8
|
西他沙星雜質(zhì)8
|
|
|
Tadalafil Impurity 42
|
他達(dá)拉非雜質(zhì)22
|
951661-82-8
|
|
Sofosbuvir IMpurity 9
|
索非布韋雜質(zhì)9
|
|
|
Sofosbuvir IMpurity 13
|
索非布韋雜質(zhì)13
|
220503-64-0
|
|
sofosbuvir impurity 17;1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
|
索非布韋雜質(zhì)17
|
|
|
Sofosbuvir IMpurity 31
|
索非布韋雜質(zhì)31
|
|
|
Sofosbuvir IMpurity 37
|
索非布韋雜質(zhì)37
|
|
|
sitafloxacin hydrate Impurity 3
|
西他沙星雜質(zhì)3
|
|
|
Sofosbuvir IMpurity 30
|
索非布韋雜質(zhì)30
|
|
|
(R)-methyl 2-acetamido-3-(1H-indol-3-yl)propanoate
|
他達(dá)拉非雜質(zhì)32
|
|
|
Tacrolimus Impurity 29
|
他克莫司雜質(zhì)2
|
131944-48-4
|
|
Solifenacin IMpurity9
|
索利那新雜質(zhì)9
|
|
|
Tadalafil Impurity 29
|
他達(dá)拉非雜質(zhì)29
|
929100-66-3
|
|
Sofosbuvir IMpurity 12
|
索非布韋雜質(zhì)12
|
|
|
sofosbuvir impurity 3
|
索非布韋雜質(zhì)3
|
|
|
Sofosbuvir IMpurity 22
|
索非布韋雜質(zhì)22
|
|
|
Riluzole Impurity 9
|
利魯唑USP相關(guān)化合物A
|
461-82-5
|
|
Sofosbuvir IMpurity 14
|
索非布韋雜質(zhì)14
|
|
|
Sofosbuvir IMpurity 34
|
索非布韋雜質(zhì)34
|
|
|
Riluzole
|
利魯唑雜質(zhì)
|
1744-22-5
|
|
Ritonavir EP Impurity B DiHCl (Monoacyl Valine DiHCl)
|
利托那韋EP雜質(zhì)B DiHCl
|
765875-58-9
|
|
Solifenacin USP IMpurity 7
|
索利那新USP雜質(zhì)7
|
|
|
Ritonavir EP Impurity T
|
利托那韋EP雜質(zhì)T
|
869368-48-9
|
|
Sarpogrelate Related Compound II
|
沙格雷酯雜質(zhì)
|
1659311-44-0
|
|
Tadalafil Impurity 12
|
他達(dá)拉非雜質(zhì)12
|
154030-29-2
|
|
Sarpogrelate Impurity 1
|
沙格雷酯雜質(zhì)
|
135261-74-4
|
|
Ritonavir EP Impurity L
|
利托那韋EP雜質(zhì)L
|
256328-82-2
|
|
Riluzole-13C-15N2
|
利魯唑雜質(zhì)
|
1215552-03-6
|
|
Sarpogrelate
|
沙格雷酯雜質(zhì)
|
125926-17-2
|
|
Ritonavir EP Impurity F
|
利托那韋EP雜質(zhì)F
|
1010809-61-6
|
|
sofosbuvir impurity 25
|
索非布韋雜質(zhì)19
|
1190308-01-0
|
|
Sofosbuvir IMpurity 23
|
索非布韋雜質(zhì)23
|
|
|
Sofosbuvir IMpurity 5
|
索非布韋雜質(zhì)5
|
|
|
Tadalafil Impurity 13
|
他達(dá)拉非雜質(zhì)13
|
1370438-57-5
|
|
Tadalafil Impurity 49
|
他達(dá)拉非雜質(zhì)
|
1356345-67-9
|
|
Riluzole impurity 6
|
利魯唑雜質(zhì)7
|
144631-82-3
|
|
sitafloxacin hydrate Impurity
|
西他沙星雜質(zhì)9鈉鹽
|
|
|
Riluzole impurity 10
|
利魯唑雜質(zhì)3（[4-（三氟甲基）苯基]硫脲）
|
1736-72-7
|
|
Ritonavir Impurity E (Hydroxy Ritonavir)
|
利托那韋雜質(zhì)E（羥
基利托那韋）
|
176655-56-4
|
|
Atorvastatin Impurity
|
阿托伐他汀雜質(zhì)
|
171596-44-4
|
|
Lactate tetramer
|
他達(dá)拉非雜質(zhì)23
|
951661-84-0
|
|
Sofosbuvir Impurity 69
|
索非布韋雜質(zhì)69
|
817204-32-3
|
|
sofosbuvir impurity 24;(R)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
|
索非布韋雜質(zhì)24
|
|
|
sitafloxacin hydrate Impurity 4
|
西他沙星雜質(zhì)4
|
|
|
Methyl Acryl Aldehyde
|
他克莫司甲基丙烯醛 雜質(zhì)對(duì)照品
|
109466-74-2
|
|
Sofosbuvir IMpurity 6
|
索非布韋雜質(zhì)6
|
|
|
Sofosbuvir IMpurity 29
|
索非布韋雜質(zhì)29
|
|
|
sitafloxacin hydrate Impurity 2
|
西他沙星雜質(zhì)2
|
|
|
Sofosbuvir IMpurity 18
|
索非布韋雜質(zhì)18
|
|
|
Sofosbuvir IMpurity 35
|
索非布韋雜質(zhì)35
|
|
|
Deubutafrazine Impurity
|
沙格雷酯雜質(zhì)
|
1659311-40-6
|
|
7-((S)-7-amino-5-azaspiro
|
西他沙星雜質(zhì)7
|
|
|
Ritonavir Geo-isomer HCl
|
利托那韋地理異構(gòu)體HCl
|
959315-21-0
|
|
Tadalafil Impurity 19
|
他達(dá)拉非雜質(zhì)19
|
477970-21-1
|
|
Sarpogrelate-d3 HCl
|
沙格雷酯雜質(zhì)
|
135159-51-2
|
|
Riluzole Impurity 6
|
利魯唑雜質(zhì)6
|
1737-06-0
|
|
Riluzole Impurity 5
|
利魯唑雜質(zhì)5
|
175278-17-8
|
|
Ritonavir EP Impurity H
|
利托那韋EP雜質(zhì)H
|
1010809-43-4
|
|
Ritonavir EP Impurity I
|
利托那韋EP雜質(zhì)I
|
165315-26-4
|
|
Ritonavir EP Impurity C
|
利托那韋EP雜質(zhì)C
|
1010808-43-1
|
|
sofosbuvir impurity 4
|
索非布韋雜質(zhì)11
|
874638-94-5
|
|
Sofosbuvir IMpurity 8
|
索非布韋雜質(zhì)8
|
|
|
Tadalafil Impurity 10
|
他達(dá)拉非雜質(zhì)10
|
100077-49-4
|
|
Sofosbuvir IMpurity 27
|
索非布韋雜質(zhì)27
|
|
|
Solifenacin EP IMpurity D
|
索利那新EP雜質(zhì)D
|
|
|
Sofosbuvir IMpurity 1
|
索非布韋雜質(zhì)1
|
|
|
Tacrolimus EP Impurity F
|
他克莫司開(kāi)環(huán)雜質(zhì)對(duì)照品
|
1393890-33-9
|
|
Tadalafil impurity 23
|
他達(dá)拉非雜質(zhì)35
|
749864-17-3
|
|
Sarpogrelate Impurity 1
|
沙格雷酯雜質(zhì)1
|
1140968-46-2
|
|
Tadalafil EP impurity D
|
他達(dá)那非EP雜質(zhì)D
|
|
|
Solifenacin USP IMpurity 5
|
索利那新USP雜質(zhì)5
|
|
|
Sofosbuvir IMpurity 28
|
索非布韋雜質(zhì)28
|
|
|
sitafloxacin hydrate Impurity 5
|
西他沙星雜質(zhì)5
|
|
|
Nintedanib Impurity 40
|
沙格雷酯雜質(zhì)
|
1659311-47-3
|
|
Tadalafil Impurity 20
|
他達(dá)拉非雜質(zhì)20
|
406938-39-4
|
|
N-Nitroso Furosemide
|
利魯唑雜質(zhì)4
|
142229-74-1
|
|
Riluzole Impurity 8
|
利魯唑4-三氟甲氧基雜質(zhì)
|
235101-36-7
|
|
Sofosbuvir Impurity 78
|
索非布韋雜質(zhì)15
|
1334513-02-8
|
|
Tadalafil Impurity 41
|
他達(dá)拉非雜質(zhì)21
|
951661-85-1
|
|
sofosbuvir impurity 1
|
索非布韋雜質(zhì)32
|
1157884-58-6
|
|
Sofosbuvir Impurity 71
|
索非布韋雜質(zhì)71
|
1884385-12-9
|
|
Riluzole Impurity 1 HCl
|
利魯唑雜質(zhì)
|
235101-44-7
|
|
sofosbuvir impurity 21;(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl benzoate
|
索非布韋雜質(zhì)21
|
1496552-50-1
|
|
Sofosbuvir IMpurity 36
|
索非布韋雜質(zhì)36
|
|
|
Tadalafil Impurity 33
|
他達(dá)拉非雜質(zhì)33
|
2170575-40-1
|